People Behind The Science Podcast - Stories From Scientists About Science, Life, Research, And Science Careers

525: Developing Gene Therapies for Rare Inherited Retinal Diseases - Dr. Daniel Chung

Informações:

Sinopsis

Dr. Daniel Chung is the global medical strategy lead for ophthalmology at Spark Therapeutics. Spark Therapeutics concentrates on discovering, developing, and delivering gene therapy for rare diseases. Dan works in the area of ophthalmology, and he and his colleagues brought the first FDA-approved gene therapy for a genetic disease to market. This therapy was created to treat an inherited retinal disease that results in blindness and is caused by variants or mutations in the RPE65 gene. When he isn’t working or traveling, Dan enjoys spending time with his family. He is also an avid photographer who loves capturing photos of nature, landscapes, and wildlife. In particular, he has really enjoyed photographing the panoramic landscapes of Monument Valley in Arizona, brown bears in Alaska, and polar bears in Northern Canada. Dan earned both his bachelor’s degree in biology and master’s degree in family counseling from Eastern Nazarene College in Massachusetts. He also holds a doctorate degree in Osteopathic Medicin